LaraƱo, Baby Girl M.

HRN: 21-35-01  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/19/2022
05/26/2022
IVT
17 Mg
24 Hrs
PROM X 17 Hrs
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: